Picture of Medicamen Organics logo

MEDIORG Medicamen Organics Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Medicamen Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
R2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSPRESSPRESS
Standards:
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2.470.78312.533.954.3
Depreciation
Deferred Taxes
Non-Cash Items4.314.075.466.344.19
Other Non-Cash Items
Changes in Working Capital-27.5-14.3-32.2-84-110
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-12.4-0.949-6.05-36.6-45.4
Capital Expenditures-6.16-2.89-3.51-24.5
Purchase of Fixed Assets
Other Investing Cash Flow Items0.4780.2170.0980.1340.948
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities0.478-5.95-2.79-3.37-23.5
Financing Cash Flow Items-4.43-4.28-5.555.5376.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities12.92.339.9940.1105
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.956-4.561.140.14935.8